The New Wave in Diagnosis and Treatment

of pelvic conditions

a digital platform for earlier diagnosis of endometriosis

This project has been funded by The European Union, under the grant agreement n° 101099775.

Funded by the European Union. Views and opinions expressed are however those of the author(s)
only and do not necessarily reflect those of the European Union and cannot be held responsible for them.

ENDOMETRIOSIS

Affects 1 in 10 individuals who menstruate

Endometriosis is caused by tissue, similar to that which lines the uterus, growing outside the uterus. 

Symptoms are highly individual.

Patients with endometriosis present with severe but non-specific symptoms, most notably chronic pelvic pain (70% of patients live with unresolved pain) and infertility (half of endometriosis patients suffer from fertility issues, and up to half of women with unexplained infertility are subsequently found to have endometriosis).

Long Diagnostic Delay​

Endometriosis is often misdiagnosed (up to 75% of cases) or remains undiagnosed for a long period of time (4-11 years from symptom onset to diagnosis).
Affects

190 million

women and people with
menstrual  cycles globally
Estimated total US
endometriosis
economic burden

$78–119 billion annually

Current therapies
manage symptoms.

No cure

OnaWave Medical

Our Mission & Vision

Our Mission

OnaWave Medical’s mission is to revolutionize pelvic healthcare by harnessing the power of biological activity and digital technology. Our aim is to provide earlier, more accurate diagnoses and effective non-invasive treatments for chronic pelvic conditions through innovative medical devices. We strive to make invisible conditions visible and empower individuals to take control of their own health.

Our Vision

OnaWave Medical’s vision is to be the leading provider of non-invasive medical solutions for chronic pelvic conditions, improving the lives of individuals worldwide through advanced technology and personalized care. We envision a future where everyone has access to effective and innovative solutions for pelvic health, breaking down barriers and advancing the field for generations to come.

Our Objectives

Making Diagnosis Earlier and Easier

Novel Digital Biomarker

Novel Digital Biomarker with potential to diagnose, monitor and treat pelvic conditions.

Earlier & Easier Diagnosis

Non-invasive medical device perscrbed by the physician and worn at home

Reduce The Cost of Diagnosis

Provide answers to reduce the time to diagnosis and mis-diagnosis

Better Patient Outcomes

Enable personalised care and potential to monitor the effectiveness of treatments

Potential for new treatment approach

Harnessing the body's own biological activity and technology in the development of new therapeutic approaches

OUR SOLUTION

Pelvic Platform

An interoperable platform with connected wearable devices bringing real time, actionable data to hospitals, physicians and patients.

Remote monitoring of a physiological marker which is altered by hormones, giving an insight into pelvic conditions. OnaWave Medical are first focusing on earlier and easier diagnosis of endometriosis. See our journey to date.

(Note: The device is not CE marked or FDA approved and is currently for research purposes only).

A Medical Technology Company
Based In The West of Ireland

Dr. Siobhán Kelleher

Founder and Chief Executive Officer

John Hegarty

Chief Operating Officer

Hari Om Aggrawal

R&D Engineer

Emily McLucas

Regulatory, Quality and Clinical Lead

OUR PARTNERS

A New Wave in Diagnosis

Heading

Seram ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.

Get In Touch

A New Wave in Diagnosis & Treatment

Hear the Inspiring Stories of Dentisto Patients

Aidan Ronan
Keira Monson
Liza Lording

Seram ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt orem ipsum dolor sit ametde consectetur adipiscing elit, sed doeiu smod tempor incidun tut labore et dolore magna alirquauis ipsum suspendisse ult rices gravida risus come modo viverra maecenaseram psum dolor sit amet, consectetur adipiscing elitsed.

Seram ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt orem ipsum dolor sit ametde consectetur adipiscing elit, sed doeiu smod tempor incidun tut labore et dolore magna alirquauis ipsum suspendisse ult rices gravida risus come modo viverra maecenaseram psum dolor sit amet, consectetur adipiscing elitsed.

Seram ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt orem ipsum dolor sit ametde consectetur adipiscing elit, sed doeiu smod tempor incidun tut labore et dolore magna alirquauis ipsum suspendisse ult rices gravida risus come modo viverra maecenaseram psum dolor sit amet, consectetur adipiscing elitsed.

4.8

Overall Rating, Based
on 2500+ Reviews.